Portfolio company
Peptone
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Peptone develops a computational biophysics platform and small-molecule therapeutics targeting intrinsically disordered proteins for pharmaceutical companies and research institutions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Pepper Bio
This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
ProtOS
This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.
Deep Origin
This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.
Dewpoint Therapeutics
This biotechnology company develops condensate-modifying small molecule drugs for patients with oncology, neurodegenerative, cardiopulmonary and metabolic diseases using an AI-enabled discovery platform.
Ten63 Therapeutics
This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
